+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Electroceutical Bioelectric Medicine Market 2024-2028

  • PDF Icon

    Report

  • 151 Pages
  • June 2024
  • Region: Global
  • TechNavio
  • ID: 5987565
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The electroceutical bioelectric medicine market is forecasted to grow by USD 7.77 billion during 2023-2028, accelerating AT a CAGR of 6.09% during the forecast period. The report on the electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of neurological disorders, increasing cardiovascular disorders, and increasing fda approval for electroceutical bioelectric medicine.

The electroceutical bioelectric medicine market is segmented as below:

By Type

  • Implantable devices
  • Non-invasive devices

By Application

  • Arrhythmia
  • Epilepsy
  • Parkinsons disease
  • Tremors
  • Others

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing research related to neurological diseases as one of the prime reasons driving the electroceutical bioelectric medicine market growth during the next few years. Also, strengthening R&D on electroceutical bioelectric medicine by vendors and increasing strategic alliances between vendors will lead to sizable demand in the market.

The report on the electroceutical bioelectric medicine market covers the following areas:

  • Electroceutical bioelectric medicine market sizing
  • Electroceutical bioelectric medicine market forecast
  • Electroceutical bioelectric medicine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroceutical bioelectric medicine market vendors that include Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, Bayer AG, Boston Scientific Corporation, Cochlear Ltd., Demant AS, electroCore Inc., EndoStim Inc, LivaNova PLC, MED EL Elektromedizinische Gerate GmbH, Medtronic, NeuroMetrix Inc., NEURONETICS Inc., NeuroPace Inc., Nevro Corp., Patricia Industries, Sonova Holding AG, Soterix Medical Inc., Synapse Biomedical Inc., and ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD. Also, the electroceutical bioelectric medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global electroceutical bioelectric medicine market 2018 - 2022
Exhibit 18: Historic Market Size - Data table on global electroceutical bioelectric medicine market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Implantable devices - Market size and forecast 2023-2028
Exhibit 34: Chart on Implantable devices - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Implantable devices - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Implantable devices - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Implantable devices - Year-over-year growth 2023-2028 (%)
6.4 Non-invasive devices - Market size and forecast 2023-2028
Exhibit 38: Chart on Non-invasive devices - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Non-invasive devices - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Non-invasive devices - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Non-invasive devices - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 44: Chart on Application - Market share 2023-2028 (%)
Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Arrhythmia - Market size and forecast 2023-2028
Exhibit 48: Chart on Arrhythmia - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Arrhythmia - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Arrhythmia - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Arrhythmia - Year-over-year growth 2023-2028 (%)
7.4 Epilepsy - Market size and forecast 2023-2028
Exhibit 52: Chart on Epilepsy - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Epilepsy - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Epilepsy - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Epilepsy - Year-over-year growth 2023-2028 (%)
7.5 Parkinsons disease - Market size and forecast 2023-2028
Exhibit 56: Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)
7.6 Tremors - Market size and forecast 2023-2028
Exhibit 60: Chart on Tremors - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Tremors - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Tremors - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Tremors - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Exhibit 64: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Application
Exhibit 68: Market opportunity by Application ($ million)
Exhibit 69: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share by geography 2023-2028 (%)
Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 111: Market opportunity by geography ($ million)
Exhibit 112: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 119: Abbott Laboratories - Overview
Exhibit 120: Abbott Laboratories - Business segments
Exhibit 121: Abbott Laboratories - Key offerings
Exhibit 122: Abbott Laboratories - Segment focus
12.4 ALEVA NEUROTHERAPEUTICS SA
Exhibit 123: ALEVA NEUROTHERAPEUTICS SA - Overview
Exhibit 124: ALEVA NEUROTHERAPEUTICS SA - Product / Service
Exhibit 125: ALEVA NEUROTHERAPEUTICS SA - Key offerings
12.5 Bayer AG
Exhibit 126: Bayer AG - Overview
Exhibit 127: Bayer AG - Business segments
Exhibit 128: Bayer AG - Key news
Exhibit 129: Bayer AG - Key offerings
Exhibit 130: Bayer AG - Segment focus
12.6 Boston Scientific Corporation
Exhibit 131: Boston Scientific Corporation - Overview
Exhibit 132: Boston Scientific Corporation - Business segments
Exhibit 133: Boston Scientific Corporation - Key news
Exhibit 134: Boston Scientific Corporation - Key offerings
Exhibit 135: Boston Scientific Corporation - Segment focus
12.7 electroCore Inc.
Exhibit 136: electroCore Inc. - Overview
Exhibit 137: electroCore Inc. - Product / Service
Exhibit 138: electroCore Inc. - Key offerings
12.8 EndoStim Inc
Exhibit 139: EndoStim Inc - Overview
Exhibit 140: EndoStim Inc - Product / Service
Exhibit 141: EndoStim Inc - Key offerings
12.9 LivaNova PLC
Exhibit 142: LivaNova PLC - Overview
Exhibit 143: LivaNova PLC - Business segments
Exhibit 144: LivaNova PLC - Key news
Exhibit 145: LivaNova PLC - Key offerings
Exhibit 146: LivaNova PLC - Segment focus
12.10 Medtronic
Exhibit 147: Medtronic - Overview
Exhibit 148: Medtronic - Business segments
Exhibit 149: Medtronic - Key news
Exhibit 150: Medtronic - Key offerings
Exhibit 151: Medtronic - Segment focus
12.11 NeuroMetrix Inc.
Exhibit 152: NeuroMetrix Inc. - Overview
Exhibit 153: NeuroMetrix Inc. - Product / Service
Exhibit 154: NeuroMetrix Inc. - Key offerings
12.12 NEURONETICS Inc.
Exhibit 155: NEURONETICS Inc. - Overview
Exhibit 156: NEURONETICS Inc. - Product / Service
Exhibit 157: NEURONETICS Inc. - Key offerings
12.13 NeuroPace Inc.
Exhibit 158: NeuroPace Inc. - Overview
Exhibit 159: NeuroPace Inc. - Product / Service
Exhibit 160: NeuroPace Inc. - Key offerings
12.14 Nevro Corp.
Exhibit 161: Nevro Corp. - Overview
Exhibit 162: Nevro Corp. - Product / Service
Exhibit 163: Nevro Corp. - Key offerings
12.15 Patricia Industries
Exhibit 164: Patricia Industries - Overview
Exhibit 165: Patricia Industries - Product / Service
Exhibit 166: Patricia Industries - Key offerings
12.16 Soterix Medical Inc.
Exhibit 167: Soterix Medical Inc. - Overview
Exhibit 168: Soterix Medical Inc. - Product / Service
Exhibit 169: Soterix Medical Inc. - Key offerings
12.17 Synapse Biomedical Inc.
Exhibit 170: Synapse Biomedical Inc. - Overview
Exhibit 171: Synapse Biomedical Inc. - Product / Service
Exhibit 172: Synapse Biomedical Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global electroceutical bioelectric medicine market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Implantable devices - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Implantable devices - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Implantable devices - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Implantable devices - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Non-invasive devices - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Non-invasive devices - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Non-invasive devices - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Non-invasive devices - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Chart on Application - Market share 2023-2028 (%)
Exhibits 45: Data Table on Application - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by Application
Exhibits 47: Data Table on Comparison by Application
Exhibits 48: Chart on Arrhythmia - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Arrhythmia - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Arrhythmia - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Arrhythmia - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Epilepsy - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Epilepsy - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Epilepsy - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Epilepsy - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Tremors - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Tremors - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Tremors - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Tremors - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 68: Market opportunity by Application ($ million)
Exhibits 69: Data Table on Market opportunity by Application ($ million)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share by geography 2023-2028 (%)
Exhibits 72: Data Table on Market share by geography 2023-2028 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 111: Market opportunity by geography ($ million)
Exhibits 112: Data Tables on Market opportunity by geography ($ million)
Exhibits 113: Impact of drivers and challenges in 2023 and 2028
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: Abbott Laboratories - Overview
Exhibits 120: Abbott Laboratories - Business segments
Exhibits 121: Abbott Laboratories - Key offerings
Exhibits 122: Abbott Laboratories - Segment focus
Exhibits 123: ALEVA NEUROTHERAPEUTICS SA - Overview
Exhibits 124: ALEVA NEUROTHERAPEUTICS SA - Product / Service
Exhibits 125: ALEVA NEUROTHERAPEUTICS SA - Key offerings
Exhibits 126: Bayer AG - Overview
Exhibits 127: Bayer AG - Business segments
Exhibits 128: Bayer AG - Key news
Exhibits 129: Bayer AG - Key offerings
Exhibits 130: Bayer AG - Segment focus
Exhibits 131: Boston Scientific Corporation - Overview
Exhibits 132: Boston Scientific Corporation - Business segments
Exhibits 133: Boston Scientific Corporation - Key news
Exhibits 134: Boston Scientific Corporation - Key offerings
Exhibits 135: Boston Scientific Corporation - Segment focus
Exhibits 136: electroCore Inc. - Overview
Exhibits 137: electroCore Inc. - Product / Service
Exhibits 138: electroCore Inc. - Key offerings
Exhibits 139: EndoStim Inc - Overview
Exhibits 140: EndoStim Inc - Product / Service
Exhibits 141: EndoStim Inc - Key offerings
Exhibits 142: LivaNova PLC - Overview
Exhibits 143: LivaNova PLC - Business segments
Exhibits 144: LivaNova PLC - Key news
Exhibits 145: LivaNova PLC - Key offerings
Exhibits 146: LivaNova PLC - Segment focus
Exhibits 147: Medtronic - Overview
Exhibits 148: Medtronic - Business segments
Exhibits 149: Medtronic - Key news
Exhibits 150: Medtronic - Key offerings
Exhibits 151: Medtronic - Segment focus
Exhibits 152: NeuroMetrix Inc. - Overview
Exhibits 153: NeuroMetrix Inc. - Product / Service
Exhibits 154: NeuroMetrix Inc. - Key offerings
Exhibits 155: NEURONETICS Inc. - Overview
Exhibits 156: NEURONETICS Inc. - Product / Service
Exhibits 157: NEURONETICS Inc. - Key offerings
Exhibits 158: NeuroPace Inc. - Overview
Exhibits 159: NeuroPace Inc. - Product / Service
Exhibits 160: NeuroPace Inc. - Key offerings
Exhibits 161: Nevro Corp. - Overview
Exhibits 162: Nevro Corp. - Product / Service
Exhibits 163: Nevro Corp. - Key offerings
Exhibits 164: Patricia Industries - Overview
Exhibits 165: Patricia Industries - Product / Service
Exhibits 166: Patricia Industries - Key offerings
Exhibits 167: Soterix Medical Inc. - Overview
Exhibits 168: Soterix Medical Inc. - Product / Service
Exhibits 169: Soterix Medical Inc. - Key offerings
Exhibits 170: Synapse Biomedical Inc. - Overview
Exhibits 171: Synapse Biomedical Inc. - Product / Service
Exhibits 172: Synapse Biomedical Inc. - Key offerings
Exhibits 173: Inclusions checklist
Exhibits 174: Exclusions checklist
Exhibits 175: Currency conversion rates for US$
Exhibits 176: Research methodology
Exhibits 177: Validation techniques employed for market sizing
Exhibits 178: Information sources
Exhibits 179: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global electroceutical bioelectric medicine market: Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, Bayer AG, Boston Scientific Corporation, Cochlear Ltd., Demant AS, electroCore Inc., EndoStim Inc, LivaNova PLC, MED EL Elektromedizinische Gerate GmbH, Medtronic, NeuroMetrix Inc., NEURONETICS Inc., NeuroPace Inc., Nevro Corp., Patricia Industries, Sonova Holding AG, Soterix Medical Inc., Synapse Biomedical Inc., and ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing research related to neurological diseases."

According to the report, one of the major drivers for this market is the growing prevalence of neurological disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • ALEVA NEUROTHERAPEUTICS SA
  • Bayer AG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Demant AS
  • electroCore Inc.
  • EndoStim Inc
  • LivaNova PLC
  • MED EL Elektromedizinische Gerate GmbH
  • Medtronic
  • NeuroMetrix Inc.
  • NEURONETICS Inc.
  • NeuroPace Inc.
  • Nevro Corp.
  • Patricia Industries
  • Sonova Holding AG
  • Soterix Medical Inc.
  • Synapse Biomedical Inc.
  • ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD.

Related Topics

Related Reports

Global Bioelectric Medicine Market Report 2024 - Product Image

Global Bioelectric Medicine Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Electroceuticals/Bioelectric Medicine Market by Product, Device, Application, End-User - Global Forecast 2025-2030 - Product Image

Electroceuticals/Bioelectric Medicine Market by Product, Device, Application, End-User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Electroceuticals Global Market Report 2024 - Product Image

Electroceuticals Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) - Forecast to 2029 - Product Image

Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) - Forecast to 2029

  • Report
  • 382 Pages
  • Global
From
Bioelectric Medicine Market by Product, Type, Indication, End-User - Global Forecast 2025-2030 - Product Image

Bioelectric Medicine Market by Product, Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.